These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11464252)

  • 21. [Antihypertensive therapy with fixed combinations].
    Holzgreve H
    Internist (Berl); 1996 Aug; 37(8):852-6. PubMed ID: 8964679
    [No Abstract]   [Full Text] [Related]  

  • 22. Combination therapy: advantages and disadvantages of first-line fixed dose therapy.
    Hall WD
    Ethn Dis; 1997; 7(2):169-71. PubMed ID: 9386957
    [No Abstract]   [Full Text] [Related]  

  • 23. Advances in treatment strategies in hypertension: the very-low-dose combination first-line.
    Stuijker Boudier HA; Zanchetti A
    J Hypertens Suppl; 2001 Nov; 19(4):S1. PubMed ID: 11848257
    [No Abstract]   [Full Text] [Related]  

  • 24. [Initial combination treatment of hypertension].
    Düsing R
    MMW Fortschr Med; 2004 Nov; 146(47):46-8. PubMed ID: 15624658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.
    Papademetriou V
    Am J Cardiol; 2009 Jan; 103(2):273-8. PubMed ID: 19121451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New perspectives in the treatment of hypertension].
    Mourad JJ
    Ann Cardiol Angeiol (Paris); 1999 Jan; 48(1):76-9. PubMed ID: 12555362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined therapy as first-line treatment for arterial hypertension].
    Glezer MG
    Ter Arkh; 2005; 77(10):93-6. PubMed ID: 16320697
    [No Abstract]   [Full Text] [Related]  

  • 28. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Medical treatment of hypertension--what treatment for what patients?].
    Zidek W; Tepel M; van der Giet M
    MMW Fortschr Med; 2004 May; 146(22):31-4. PubMed ID: 15373106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perindopril + indapamide: new preparation. Simple trick.
    Prescrire Int; 1999 Dec; 8(44):172-5. PubMed ID: 11503814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
    Gosse P
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale for the use of very-low-dose combinations as first-line treatment of hypertension.
    Waeber B; Brunner HR
    J Hypertens Suppl; 2001 Nov; 19(4):S3-8. PubMed ID: 11848261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antihypertensive first-line and add-on treatment with a fixed controlled release combination of metoprololsuccinate/hydrochlorothiazide. Prospective doctor's office observational study in 14,964 patients].
    Hildemann SK; Fischer HM; Pittrow D; Bohlscheid V
    Fortschr Med Orig; 2003; 121(1):27-32. PubMed ID: 15117066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Healthcare benefits of very-low-dose combination treatment used in the management of hypertension.
    Ambrosioni E
    J Hypertens Suppl; 2001 Nov; 19(4):S29-36. PubMed ID: 11848260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of free and fixed drug combinations to improve hypertension control in our populations.
    Chalmers J
    Eur Heart J; 1999 Aug; 20(15):1060-1. PubMed ID: 10413632
    [No Abstract]   [Full Text] [Related]  

  • 37. High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension.
    Andreadis EA; Tsourous GI; Marakomichelakis GE; Katsanou PM; Fotia ME; Vassilopoulos CV; Diamantopoulos EJ
    J Hum Hypertens; 2005 Jun; 19(6):491-6. PubMed ID: 15759025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of a fixed-dose combination of trandolapril-verapamil in obese hypertensive patients resistant to monotherapy.
    Rubio-Guerra AF; Lozano-Nuevo JJ; Vargas-Ayala G; Rodríguez-López L; Ramos-Brizuela LM; Escalante-Acosta BA
    Clin Exp Hypertens; 2006 Oct; 28(7):619-24. PubMed ID: 17060060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
    Caro JJ; Lee K
    Curr Hypertens Rep; 2002 Dec; 4(6):417-8. PubMed ID: 12419166
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antihypertensive therapy according to the ESH/ESC guidelines].
    Waeber B; Feihl F
    Rev Med Suisse; 2007 Sep; 3(124):2003-4, 2006. PubMed ID: 17955827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.